| Primary |
| Hiv Infection |
62.9% |
| Antiretroviral Therapy |
9.5% |
| Antiviral Treatment |
9.2% |
| Drug Use For Unknown Indication |
4.8% |
| Antiviral Prophylaxis |
4.3% |
| Prophylaxis Against Hiv Infection |
2.2% |
| Product Used For Unknown Indication |
1.4% |
| Prophylaxis |
1.1% |
| Acquired Immunodeficiency Syndrome |
1.0% |
| Tuberculosis |
0.9% |
| Retroviral Infection |
0.5% |
| Viral Infection |
0.4% |
| Cerebral Toxoplasmosis |
0.4% |
| Hiv Test Positive |
0.3% |
| Depression |
0.3% |
| Hepatitis C |
0.2% |
| Systemic Antiviral Treatment |
0.2% |
| Hypertension |
0.1% |
| Contraception |
0.1% |
| Pain |
0.1% |
|
| Drug Exposure During Pregnancy |
28.4% |
| Stillbirth |
10.2% |
| Vomiting |
7.8% |
| Maternal Exposure During Pregnancy |
5.9% |
| Premature Baby |
5.3% |
| Abortion Spontaneous |
4.9% |
| Weight Decreased |
4.9% |
| Ventricular Septal Defect |
4.4% |
| Pyrexia |
4.0% |
| Foetal Exposure During Pregnancy |
3.0% |
| Polydactyly |
3.0% |
| Hepatitis |
2.9% |
| Pregnancy |
2.3% |
| Premature Labour |
2.3% |
| Live Birth |
2.2% |
| Intra-uterine Death |
2.0% |
| Talipes |
1.9% |
| Trisomy 21 |
1.9% |
| Anaemia |
1.5% |
| Pancytopenia |
1.5% |
|
| Secondary |
| Hiv Infection |
45.2% |
| Drug Exposure During Pregnancy |
12.4% |
| Antiretroviral Therapy |
5.0% |
| Drug Use For Unknown Indication |
4.9% |
| Hiv Test Positive |
3.9% |
| Prophylaxis |
3.9% |
| Maternal Exposure Timing Unspecified |
3.9% |
| Acquired Immunodeficiency Syndrome |
3.6% |
| Human Immunodeficiency Virus Transmission |
2.9% |
| Product Used For Unknown Indication |
2.8% |
| Antiviral Prophylaxis |
2.1% |
| Antiviral Treatment |
1.9% |
| Prophylaxis Against Hiv Infection |
1.5% |
| Maternal Exposure During Pregnancy |
1.0% |
| Antifungal Prophylaxis |
1.0% |
| Anxiety |
0.9% |
| Back Pain |
0.8% |
| Chest Discomfort |
0.8% |
| Hypertension |
0.8% |
| Cancer Pain |
0.7% |
|
| Drug Exposure During Pregnancy |
16.4% |
| Abortion Spontaneous |
11.6% |
| Pregnancy |
11.0% |
| Vomiting |
7.9% |
| Premature Baby |
7.7% |
| Stillbirth |
7.6% |
| Foetal Exposure During Pregnancy |
4.6% |
| Trisomy 21 |
4.1% |
| Microcephaly |
3.8% |
| Abortion Induced |
2.8% |
| Normal Newborn |
2.5% |
| Anaemia |
2.4% |
| Diabetes Mellitus |
2.4% |
| Intra-uterine Death |
2.4% |
| Neutropenia |
2.3% |
| Ultrasound Antenatal Screen Abnormal |
2.2% |
| Ventricular Septal Defect |
2.2% |
| Maternal Exposure During Pregnancy |
2.0% |
| Pre-eclampsia |
2.0% |
| Maternal Drugs Affecting Foetus |
1.9% |
|
| Concomitant |
| Hiv Infection |
58.7% |
| Drug Exposure During Pregnancy |
8.2% |
| Product Used For Unknown Indication |
6.1% |
| Drug Use For Unknown Indication |
4.2% |
| Prophylaxis |
3.2% |
| Hiv Test Positive |
2.0% |
| Acquired Immunodeficiency Syndrome |
1.8% |
| Prophylaxis Against Hiv Infection |
1.6% |
| Maternal Exposure Timing Unspecified |
1.5% |
| Antifungal Prophylaxis |
1.5% |
| Depression |
1.5% |
| Exposure During Pregnancy |
1.5% |
| Antiretroviral Therapy |
1.4% |
| Hypertension |
1.2% |
| Asthma |
1.2% |
| Pathogen Resistance |
1.1% |
| Maternal Exposure During Pregnancy |
1.0% |
| Tuberculosis |
0.9% |
| Diabetes Mellitus |
0.8% |
| Antiviral Treatment |
0.7% |
|
| Abortion Spontaneous |
11.9% |
| Pregnancy |
9.9% |
| Stillbirth |
9.5% |
| Vomiting |
8.9% |
| Osteonecrosis |
5.3% |
| Premature Baby |
5.3% |
| Pyrexia |
5.1% |
| Renal Failure |
4.8% |
| Rash |
4.0% |
| Pancreatitis |
3.8% |
| Small For Dates Baby |
3.8% |
| Myocardial Infarction |
3.6% |
| Polydactyly |
3.6% |
| Drug Exposure During Pregnancy |
3.4% |
| Abortion Induced |
3.0% |
| Premature Labour |
3.0% |
| Renal Failure Acute |
3.0% |
| Pain |
2.8% |
| Pain In Extremity |
2.8% |
| Talipes |
2.8% |
|
| Interacting |
| Hiv Infection |
40.0% |
| Drug Use For Unknown Indication |
16.0% |
| Hepatitis C |
8.0% |
| Hepatitis C Virus |
8.0% |
| Prophylaxis |
6.0% |
| Neoplasm Malignant |
4.0% |
| Retroviral Infection |
4.0% |
| Adrenal Insufficiency |
2.0% |
| Attention Deficit/hyperactivity Disorder |
2.0% |
| Bipolar I Disorder |
2.0% |
| Bronchiectasis |
2.0% |
| Coagulopathy |
2.0% |
| Contraception |
2.0% |
| Osteoporosis |
2.0% |
|
| Drug Interaction |
21.4% |
| Polyneuropathy |
14.3% |
| Throat Cancer |
14.3% |
| International Normalised Ratio Decreased |
7.1% |
| Neutropenia |
7.1% |
| Pregnancy |
7.1% |
| Secondary Adrenocortical Insufficiency |
7.1% |
| T-lymphocyte Count Decreased |
7.1% |
| Tachypnoea |
7.1% |
| Vomiting |
7.1% |
|
